Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: Are the available data convincing?

Umberto Malapelle, Antonio Rossi, Emilio Bria

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)S1837-S1840
JournalJournal of Thoracic Disease
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this